About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Life-Saving Drug Prices To Rise Due To Withdrawal Of Customs Duty Exemption

by Shirley Johanna on February 8, 2016 at 3:50 PM
Font : A-A+

Life-Saving Drug Prices To Rise Due To Withdrawal Of Customs Duty Exemption

As the government has withdrawn customs duty exemption on their imports, around 74 drugs including life-saving drugs will see a sharp rise in prices.

The notification was issued last week by the Central Board of Excise and Customs (CBEC) withdrawing the exemption from levy of basic customs duty on 74 drugs.

Advertisement


D G Shah, Secretary General of the Indian Pharmaceutical Alliance, said, "The recommendation to prune the lists was aimed mainly at taking stock of the current status of the industry and to rationalize the exemptions."

"It also aimed at promoting the local production of bulk drugs and reduce dependence on cheap imports from China. It is thus aligned with the overall objective of reviving the bulk drug industry in the country," said Shah.
Advertisement

The entire exercise took over 12 months. The main reason was to update the lists drawn in 2012 and promote the revival of the domestic production of bulk drug, he said.

"As the customs duty waiver is withdrawn, the formulators would prefer to use domestic bulk and thereby create demand for the local production. This is also in the long-term interests of the consumer, as it will reduce dependence on vagaries of imports," said Shah.

The customs duty will be imposed on drugs to treat cancer, kidney stones, diabetes, Parkinson's disease, bone disease, heart rhythm disorders, drugs used in chemotherapy, radiotherapy and antibiotics to treat infections.

There will be a spurt in prices for drugs to treat HIV, leukemia, hepatitis B, allergies, arthritis, lupus and ulcerative colitis.

"The withdrawal of exemption from basic customs duty for certain drugs and medicines including life-saving drugs is intended to provide protection to the domestic manufacturing industry and enhance the attractiveness of make in India initiative," said Sachin Menon, KPMG India Partner and Head of Indirect Tax.

"The move seems to be in line with the government's objective to rationalize the duty exemptions," said Menon.

"An increase has also been made in the customs duty rates of certain life saving drugs such as abciximab, anti-rabies immunoglobin, FSH, procarbazine and saquinavir to 35 per cent," said MS Mani, Senior Director of Deloitte in India.

These changes signify the intention of the government to promote domestic manufacture of these items as imports would now become more expensive, said Mani.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
Test Your Knowledge About Chromosomes?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 

Most Popular on Medindia

Diaphragmatic Hernia The Essence of Yoga Vent Forte (Theophylline) Drug Interaction Checker Turmeric Powder - Health Benefits, Uses & Side Effects Indian Medical Journals Accident and Trauma Care Iron Intake Calculator Drug Side Effects Calculator Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Life-Saving Drug Prices To Rise Due To Withdrawal Of Customs Duty Exemption Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests